Sort by
Refine Your Search
-
rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering
-
. graduates in various areas of industry pharmacy including regulatory affairs, medical information/affairs, patient safety, outcomes research, and many other areas. The program is a collaboration between
-
diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause
-
. graduates in various areas of industry pharmacy including regulatory affairs, medical information/affairs, patient safety, outcomes research, and many other areas. The program is a collaboration between
-
to develop a proficient understanding of Medical Affairs, including analyzing, developing and delivering scientifically-balanced data to healthcare providers to improve patient outcomes. Throughout
-
Department of Pharmacy & Health System Sciences Director of Pharmaceutical Industry Fellowship Program 360 Huntington Ave, 140TF R218 Boston, MA 02115 Position Type Research Additional Information Northeastern
-
afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by
-
. graduates in various areas of industry pharmacy including regulatory affairs, medical information/affairs, patient safety, outcomes research, and many other areas. The program is a collaboration between
-
Development to provide and communicate the most up to date scientific information Qualifications: Doctor of Pharmacy degree from an ACPE accredited institution, eligible for licensure as a pharmacist in the US
-
an understanding of the barriers facing individuals from groups marginalized in your field and be in alignment with the College of Science's Culture of Respect . Some candidates may not have substantial past